In India, June Was An Odd Month As Sales Disappointed But Future Looks Bright
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - For the thousands of medical representatives in India chasing aggressive targets, June is a critical month as it marks the start of the monsoon season. Monsoons last four months as heavy rains lead to a surge in cases of infectious diseases, diarrhea, asthma and respiratory issues. Sales of medicines as such are remarkably higher in these months compared to the rest of the year. But this year, June has been an odd and rather disappointing month, with sales growing at just 12.6%, down almost 2% from May which showed a growth of 14.5%
You may also be interested in...
Extended Monsoons Help Pep Up Sales In India; Anti-infectives Show Revival In August
MUMBAI - Heavy monsoon rains during the month of August helped the Indian pharmaceutical industry revive from its sagging July sales as the anti-infectives market showed signs of picking up momentum
Extended Monsoons Help Pep Up Sales In India; Anti-infectives Show Revival In August
MUMBAI - Heavy monsoon rains during the month of August helped the Indian pharmaceutical industry revive from its sagging July sales as the anti-infectives market showed signs of picking up momentum
India's Sales Rankings Shuffle As IMS Health Widens Audit To Hospitals And Doctors
MUMBAI - GlaxoSmithKline PLC gained the top sales slot in India with Augmentin (amoxicillin/clavulanate) as a result of data analysis firm IMS Health expanding its sales audit coverage in the country